BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 10796715)

  • 1. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
    Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
    Furness S; Roberts H; Marjoribanks J; Lethaby A; Hickey M; Farquhar C
    Cochrane Database Syst Rev; 2009 Apr; (2):CD000402. PubMed ID: 19370558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.
    Furness S; Roberts H; Marjoribanks J; Lethaby A
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD000402. PubMed ID: 22895916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclical progestogens for heavy menstrual bleeding.
    Lethaby A; Irvine G; Cameron I
    Cochrane Database Syst Rev; 2000; (2):CD001016. PubMed ID: 10796587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA; Young K; Hickey M; Su HI
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
    Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
    Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation.
    Hickey M; Higham J; Fraser IS
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001895. PubMed ID: 17943761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
    Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
    Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
    BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation.
    Hickey M; Higham J; Fraser IS
    Cochrane Database Syst Rev; 2000; (2):CD001895. PubMed ID: 10796833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclical progestogens for heavy menstrual bleeding.
    Lethaby A; Irvine G; Cameron I
    Cochrane Database Syst Rev; 2008 Jan; (1):CD001016. PubMed ID: 18253983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclical progestogens for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Low C; Cameron IT
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD001016. PubMed ID: 31425626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.